Cargando…
Human Leukocyte Antigen Class I and II Knockout Human Induced Pluripotent Stem Cell–Derived Cells: Universal Donor for Cell Therapy
BACKGROUND: We aim to generate a line of “universal donor” human induced pluripotent stem cells (hiPSCs) that are nonimmunogenic and, therefore, can be used to derive cell products suitable for allogeneic transplantation. METHODS AND RESULTS: hiPSCs carrying knockout mutations for 2 key components (...
Autores principales: | Mattapally, Saidulu, Pawlik, Kevin M., Fast, Vladimir G., Zumaquero, Esther, Lund, Frances E., Randall, Troy D., Townes, Tim M., Zhang, Jianyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6405542/ https://www.ncbi.nlm.nih.gov/pubmed/30488760 http://dx.doi.org/10.1161/JAHA.118.010239 |
Ejemplares similares
-
Correction: Maturation of three-dimensional, hiPSC-derived cardiomyocyte spheroids utilizing cyclic, uniaxial stretch and electrical stimulation
por: LaBarge, Wesley, et al.
Publicado: (2019) -
Efficient CRISPR/Cas9-Mediated Versatile, Predictable, and Donor-Free Gene Knockout in Human Pluripotent Stem Cells
por: Liu, Zhongliang, et al.
Publicado: (2016) -
Knockout of the CEP290 gene in human induced pluripotent stem cells
por: Fogerty, Joseph, et al.
Publicado: (2021) -
Broad T-Cell Receptor Repertoire in T-Lymphocytes Derived from Human Induced Pluripotent Stem Cells
por: Chang, Chia-Wei, et al.
Publicado: (2014) -
Bioreactor Suspension Culture: Differentiation and Production of Cardiomyocyte Spheroids From Human Induced Pluripotent Stem Cells
por: Kahn-Krell, Asher, et al.
Publicado: (2021)